BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18292238)

  • 1. A natural polymorphism in peroxisome proliferator-activated receptor-alpha hinge region attenuates transcription due to defective release of nuclear receptor corepressor from chromatin.
    Liu MH; Li J; Shen P; Husna B; Tai ES; Yong EL
    Mol Endocrinol; 2008 May; 22(5):1078-92. PubMed ID: 18292238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.
    Krogsdam AM; Nielsen CA; Neve S; Holst D; Helledie T; Thomsen B; Bendixen C; Mandrup S; Kristiansen K
    Biochem J; 2002 Apr; 363(Pt 1):157-65. PubMed ID: 11903058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein.
    Dowell P; Ishmael JE; Avram D; Peterson VJ; Nevrivy DJ; Leid M
    J Biol Chem; 1999 May; 274(22):15901-7. PubMed ID: 10336495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of multiple Lis-Homology domain/WD-40 repeat-containing proteins in feed-forward transcriptional repression by silencing mediator for retinoic and thyroid receptor/nuclear receptor corepressor complexes.
    Choi HK; Choi KC; Kang HB; Kim HC; Lee YH; Haam S; Park HG; Yoon HG
    Mol Endocrinol; 2008 May; 22(5):1093-104. PubMed ID: 18202150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mechanism of thyroid hormone-dependent negative regulation by thyroid hormone receptor, nuclear receptor corepressor (NCoR), and GAGA-binding factor on the rat cD44 promoter.
    Kim SW; Ho SC; Hong SJ; Kim KM; So EC; Christoffolete M; Harney JW
    J Biol Chem; 2005 Apr; 280(15):14545-55. PubMed ID: 15701601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesion.
    Battaglia S; Maguire O; Thorne JL; Hornung LB; Doig CL; Liu S; Sucheston LE; Bianchi A; Khanim FL; Gommersall LM; Coulter HS; Rakha S; Giddings I; O'Neill LP; Cooper CS; McCabe CJ; Bunce CM; Campbell MJ
    Carcinogenesis; 2010 Sep; 31(9):1650-60. PubMed ID: 20466759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2.
    Guo C; Li Y; Gow CH; Wong M; Zha J; Yan C; Liu H; Wang Y; Burris TP; Zhang J
    J Biol Chem; 2015 Feb; 290(6):3666-79. PubMed ID: 25519902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoR.
    Pourcet B; Pineda-Torra I; Derudas B; Staels B; Glineur C
    J Biol Chem; 2010 Feb; 285(9):5983-92. PubMed ID: 19955185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor.
    Cheng S; Brzostek S; Lee SR; Hollenberg AN; Balk SP
    Mol Endocrinol; 2002 Jul; 16(7):1492-501. PubMed ID: 12089345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PXR Suppresses PPARα-Dependent
    Shizu R; Ezaki K; Sato T; Sugawara A; Hosaka T; Sasaki T; Yoshinari K
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone.
    Safer JD; Cohen RN; Hollenberg AN; Wondisford FE
    J Biol Chem; 1998 Nov; 273(46):30175-82. PubMed ID: 9804773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARα and NCOR/SMRT corepressor network in liver metabolic regulation.
    Kang Z; Fan R
    FASEB J; 2020 Jul; 34(7):8796-8809. PubMed ID: 32396271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists.
    Hodgson MC; Astapova I; Cheng S; Lee LJ; Verhoeven MC; Choi E; Balk SP; Hollenberg AN
    J Biol Chem; 2005 Feb; 280(8):6511-9. PubMed ID: 15598662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPARα).
    Thomas M; Burk O; Klumpp B; Kandel BA; Damm G; Weiss TS; Klein K; Schwab M; Zanger UM
    Mol Pharmacol; 2013 Mar; 83(3):709-18. PubMed ID: 23295386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dominant negative human peroxisome proliferator-activated receptor (PPAR){alpha} is a constitutive transcriptional corepressor and inhibits signaling through all PPAR isoforms.
    Semple RK; Meirhaeghe A; Vidal-Puig AJ; Schwabe JW; Wiggins D; Gibbons GF; Gurnell M; Chatterjee VK; O'Rahilly S
    Endocrinology; 2005 Apr; 146(4):1871-82. PubMed ID: 15661858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity.
    Stanley TB; Leesnitzer LM; Montana VG; Galardi CM; Lambert MH; Holt JA; Xu HE; Moore LB; Blanchard SG; Stimmel JB
    Biochemistry; 2003 Aug; 42(31):9278-87. PubMed ID: 12899614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735.
    Stevens A; Garside H; Berry A; Waters C; White A; Ray D
    Mol Endocrinol; 2003 May; 17(5):845-59. PubMed ID: 12569182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity.
    Gervois P; Torra IP; Chinetti G; Grötzinger T; Dubois G; Fruchart JC; Fruchart-Najib J; Leitersdorf E; Staels B
    Mol Endocrinol; 1999 Sep; 13(9):1535-49. PubMed ID: 10478844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain.
    Juge-Aubry CE; Hammar E; Siegrist-Kaiser C; Pernin A; Takeshita A; Chin WW; Burger AG; Meier CA
    J Biol Chem; 1999 Apr; 274(15):10505-10. PubMed ID: 10187842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.